New frontiers in primary immunodeficiency disorders: immunology and beyond….
about
An in silico platform for the design of heterologous pathways in nonnative metabolite productionHigh-throughput fluorescence anisotropy screen for inhibitors of the oncogenic mRNA binding protein, IMP-1.Increased neutrophil oxidative burst metabolism in systemic lupus erythematosus.Role of circulatory microRNAs in the pathogenesis of hepatitis C virus.
P2860
New frontiers in primary immunodeficiency disorders: immunology and beyond….
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New frontiers in primary immunodeficiency disorders: immunology and beyond….
@en
New frontiers in primary immunodeficiency disorders: immunology and beyond….
@nl
type
label
New frontiers in primary immunodeficiency disorders: immunology and beyond….
@en
New frontiers in primary immunodeficiency disorders: immunology and beyond….
@nl
prefLabel
New frontiers in primary immunodeficiency disorders: immunology and beyond….
@en
New frontiers in primary immunodeficiency disorders: immunology and beyond….
@nl
P2860
P1476
New frontiers in primary immunodeficiency disorders: immunology and beyond….
@en
P2093
Eleonora Gambineri
P2860
P2888
P356
10.1007/S00018-011-0833-0
P577
2011-10-19T00:00:00Z